WO2003061684A3 - Tumour treatment compositions comprising hsp70 and tumour necrosis factor - Google Patents

Tumour treatment compositions comprising hsp70 and tumour necrosis factor Download PDF

Info

Publication number
WO2003061684A3
WO2003061684A3 PCT/EP2003/000786 EP0300786W WO03061684A3 WO 2003061684 A3 WO2003061684 A3 WO 2003061684A3 EP 0300786 W EP0300786 W EP 0300786W WO 03061684 A3 WO03061684 A3 WO 03061684A3
Authority
WO
WIPO (PCT)
Prior art keywords
tumour
hsp70
necrosis factor
treatment compositions
tumour necrosis
Prior art date
Application number
PCT/EP2003/000786
Other languages
French (fr)
Other versions
WO2003061684A2 (en
Inventor
Claude Libert
Ben Wielockx
Molle Wim Van
Tina Mahieu
Original Assignee
Vlaams Interuniv Inst Biotech
Universitei Gent
Claude Libert
Ben Wielockx
Molle Wim Van
Tina Mahieu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniv Inst Biotech, Universitei Gent, Claude Libert, Ben Wielockx, Molle Wim Van, Tina Mahieu filed Critical Vlaams Interuniv Inst Biotech
Priority to AU2003218639A priority Critical patent/AU2003218639A1/en
Publication of WO2003061684A2 publication Critical patent/WO2003061684A2/en
Publication of WO2003061684A3 publication Critical patent/WO2003061684A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

The invention relates to a novel pharmaceutical composition comprising HSP70 and tumour necrosis factor and its use in systemic tumour treatment.
PCT/EP2003/000786 2002-01-24 2003-01-24 Tumour treatment compositions comprising hsp70 and tumour necrosis factor WO2003061684A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003218639A AU2003218639A1 (en) 2002-01-24 2003-01-24 Tumour treatment compositions comprising hsp70 and tumour necrosis factor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075297 2002-01-24
EP02075297.8 2002-01-24

Publications (2)

Publication Number Publication Date
WO2003061684A2 WO2003061684A2 (en) 2003-07-31
WO2003061684A3 true WO2003061684A3 (en) 2004-01-15

Family

ID=27589134

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/000786 WO2003061684A2 (en) 2002-01-24 2003-01-24 Tumour treatment compositions comprising hsp70 and tumour necrosis factor

Country Status (2)

Country Link
AU (1) AU2003218639A1 (en)
WO (1) WO2003061684A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008523055A (en) * 2004-12-10 2008-07-03 ゼルニケ ビジネス サポート ビー．ヴィー． Heat shock protein (HSP) and supraventricular arrhythmia
ES2532083T3 (en) * 2008-06-26 2015-03-24 Orphazyme Aps Use of Hsp70 as a regulator of enzymatic activity
CN103338784A (en) 2010-11-30 2013-10-02 奥菲泽米有限公司 Methods for increasing intracellular activity of Hsp70
JP6678676B2 (en) 2014-09-15 2020-04-08 オーファザイム エー／エス Arimoclomol formulation
EP3442530A1 (en) 2016-04-13 2019-02-20 Orphazyme A/S Heat shock proteins and cholesterol homeostasis
WO2017186919A1 (en) 2016-04-29 2017-11-02 Orphazyme Aps Arimoclomol for treating glucocerebrosidase associated disorders
IL303026A (en) 2020-11-19 2023-07-01 Zevra Denmark As Processes for preparing arimoclomol citrate and intermediates thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JAATTELA, MARJA ET AL: "Heat-shock proteins protect cells from monocyte cytotoxicity: Possible mechanism of self-protection", J. EXP. MED. (1993), 177(1), 231-6, XP002943877 *
JAATTELA, MARJA: "Over-expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells", INT. J. CANCER (1995), 60(5), 689-93, XP008004374 *
KIM, YOUNG-MYEONG ET AL: "Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor -.alpha.-induced apoptosis by inducing heat shock protein 70 expression", J. BIOL. CHEM. (1997), 272(2), 1402-1411, XP001077875 *

Also Published As

Publication number Publication date
AU2003218639A1 (en) 2003-09-02
WO2003061684A2 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
IL233352A0 (en) Rna molecules and pharmaceutical compositions containing the same and uses thereof
IL213597A0 (en) Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL231576A (en) Adamantyl-acetamide derivatives, pharmaceutical compositions comprising same and use thereof in the manufacture of medicaments
EP1587482A4 (en) Anti-inflammatory compositions and uses thereof
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
IL163894A (en) 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
HK1080865A1 (en) Novel nonsteroidal anti-inflammatory substances, compositions and methods ; for their use
IL164845A (en) 2-(alpha-hydroxypentyl)benzoate, its preparation, pharmaceutical compositions comprising it and their use in the preparation of medicaments
AU2003220786A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
AU2003250372A1 (en) Pharmaceutical composition
HK1081864A1 (en) Anti-inflammatory compositions and use of the same in the manufacture of medicaments
WO2003074006A3 (en) Compositions and methods for preventing sporadic neoplasia in colon
ZA200210316B (en) Composition and its therapeutic use.
AU2003272903A1 (en) Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
WO2003061684A3 (en) Tumour treatment compositions comprising hsp70 and tumour necrosis factor
AU2003231486A1 (en) Difructose anhydride-containing composition and use thereof
PL361364A1 (en) Peptide and pharmaceutical composition as well as their therapeutic applications
AU2003284460A1 (en) Medicinal composition
AU2002358337A1 (en) Novel retinol derivative and cosmetic composition comprising the same
AU2003280799A1 (en) Medicinal composition
AU2003258772A1 (en) Novel neutracetical and pharmaceutical compositions and their uses
AU2003271854A1 (en) Composition comprising proteinaceous material, its preparation and use
AU2003223992A1 (en) Solid stabilizer composition, the production and the use thereof
AU2003205974A1 (en) Pharmaceutical compositions comprising terbutaline or salbutamol in combination with guaiphenesine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP